These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22779103)

  • 21. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
    Vakirlis E; Kastanis A; Lazaridou E; Loannides D; Chrysomallis F
    Int J Clin Pharmacol Res; 2005; 25(4):165-8. PubMed ID: 16402632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
    Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
    Scarpa C
    Acta Derm Venereol Suppl (Stockh); 1994; 186():47. PubMed ID: 8073835
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
    Tzung TY; Chen CY; Yang CY; Lo PY; Chen YH
    Acta Derm Venereol; 2008; 88(3):279-80. PubMed ID: 18480933
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus ointment improves psoriasis in a microplaque assay.
    Remitz A; Reitamo S; Erkko P; Granlund H; Lauerma AI
    Br J Dermatol; 1999 Jul; 141(1):103-7. PubMed ID: 10417522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
    Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
    Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
    Carroll CL; Clarke J; Camacho F; Balkrishnan R; Feldman SR
    Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study.
    Ortonne JP; van de Kerkhof PC; Prinz JC; Bieber T; Lahfa M; Rubins A; Wozel G; Lorette G;
    Acta Derm Venereol; 2006; 86(1):29-33. PubMed ID: 16585986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
    Scheinfeld NS
    Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.